NeuroMetrix Q1 EPS $(1.67) Down From $(1.64) YoY, Sales $1.09M Down From $1.73M YoY
Portfolio Pulse from Benzinga Newsdesk
NeuroMetrix (NASDAQ:NURO) reported a Q1 EPS of $(1.67), a slight increase in losses from $(1.64) YoY, and sales of $1.09M, a 36.64% decrease from $1.73M YoY.
May 15, 2024 | 8:07 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
NeuroMetrix reported a Q1 EPS of $(1.67), a slight increase in losses from $(1.64) YoY, and sales of $1.09M, a 36.64% decrease from $1.73M YoY.
The reported increase in losses and significant decrease in sales are likely to negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100